Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pierre Fabre Hopes To Enter US Cancer Space With Atara’s Ebvallo

Nov 03 2023

• By Joseph Haas

Cell therapy — Pierre Fabre licenses US rights to cell therapy Ebvallo • Source: Shutterstock

Related Content

A Master Of Firsts: Pascal Touchon On Atara Bio And The Maturing Cell Therapy Ecosystem

Jun 15 2023

Pierre Fabre Fights Off Rivals For Rights To Atara's Allogeneic T-Cell Therapy

Oct 08 2021

Pierre Fabre Continues Oncology R&D Push

Sep 25 2023

Related Companies

Pierre Fabre

Atara Biotherapeutics, Inc.

Vernalis PLC

Additional Topics

Deals Business Strategies ImmunoOncology Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.